Literature DB >> 19800703

Lipiodol injection for target volume delineation and image guidance during radiotherapy for bladder cancer.

Floris Pos1, Axel Bex, Hermina Maria Dees-Ribbers, Anja Betgen, Marcel van Herk, Peter Remeijer.   

Abstract

A technique was developed for bladder tumour demarcation with lipiodol injection through a flexible cystoscope. The technique proved to be simple and useful for image-guided radiotherapy in bladder cancer as well as a helpful aid in the tumour delineation process.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19800703     DOI： 10.1016/j.radonc.2009.09.003

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


  11 in total

1.  Lipiodol injections for optimization of target volume delineation in a patient with a second tumor of the oropharynx: A case report.

Authors:  Marlen Haderlein; Ricarda Merten; Andrea Stojanovic; Stefan Speer; Claudia Scherl; Rainer Fietkau; Oliver J Ott
Journal:  Strahlenther Onkol       Date:  2015-06-04       Impact factor: 3.621

2.  Combination therapy: hypoxia modification with radiotherapy for bladder cancer.

Authors:  Mary Gospodarowicz
Journal:  Nat Rev Clin Oncol       Date:  2011-02-01       Impact factor: 66.675

3.  A retrospective review of the long-term outcomes of online adaptive radiation therapy and conventional radiation therapy for muscle invasive bladder cancer.

Authors:  Janice Yeh; Mathias Bressel; Keen Hun Tai; Tomas Kron; Farshad Foroudi
Journal:  Clin Transl Radiat Oncol       Date:  2021-08-06

4.  Independent position correction on tumor and lymph nodes; consequences for bladder cancer irradiation with two combined IMRT plans.

Authors:  Dominique C van Rooijen; René Pool; Jeroen B van de Kamer; Maarten C C M Hulshof; Caro C E Koning; Arjan Bel
Journal:  Radiat Oncol       Date:  2010-06-15       Impact factor: 3.481

5.  Calcium Phosphate Cement Paste Injection as a Fiducial Marker of Cervical Cancer.

Authors:  Ichiro Ogino; Masakazu Kitagawa; Shigenobu Watanabe; Hiroshi Yoshida; Masaharu Hata
Journal:  In Vivo       Date:  2018 Nov-Dec       Impact factor: 2.155

6.  Potential for BioXmark liquid fiducial marker to improve identification of superficial component of canine oral tumors for computer-based radiation therapy planning.

Authors:  Benoit Clerc-Renaud; Mary-Keara Boss; Lynn R Griffin; Susan M LaRue; Del Leary
Journal:  Can Vet J       Date:  2019-10       Impact factor: 1.008

Review 7.  MR-Guided Adaptive Radiotherapy for Bladder Cancer.

Authors:  Adham Hijab; Boris Tocco; Ian Hanson; Hanneke Meijer; Christina Junker Nyborg; Anders Smedegaard Bertelsen; Robert Jan Smeenk; Gillian Smith; Jeff Michalski; Brian C Baumann; Shaista Hafeez
Journal:  Front Oncol       Date:  2021-02-25       Impact factor: 6.244

8.  Exploratory models comparing ethiodized oil-glue and gold fiducials for bladder radiotherapy image-guidance.

Authors:  Daryl Lim Joon; Alexandra Berlangieri; Benjamin Harris; Mark Tacey; Rachel O'Meara; Brent Pitt; Angela Viotto; Kerryn Brown; Michal Schneider; Nathan Lawrentschuk; Shomik Sengupta; Colleen Berry; Trish Jenkins; Michael Chao; Morikatsu Wada; Farshad Foroudi; Vincent Khoo
Journal:  Phys Imaging Radiat Oncol       Date:  2021-02-06

9.  BioXmark® liquid fiducial markers for image-guided radiotherapy in muscle invasive bladder cancer: a safety and performance trial.

Authors:  Mischa de Ridder; Lara C Gerbrandy; Theo M de Reijke; Karel A Hinnen; Maarten C C M Hulshof
Journal:  Br J Radiol       Date:  2020-06-01       Impact factor: 3.039

10.  Trimodality bladder-sparing approach without neoadjuvant chemotherapy for node-negative localized muscle-invasive urinary bladder cancer resulted in comparable cystectomy-free survival.

Authors:  Cheng-Yen Lee; Kai-Lin Yang; Hui-Ling Ko; Rong-Yau Huang; Pei-Pin Tsai; Ming-Tsun Chen; Yi-Chia Lin; Thomas I-Sheng Hwang; Guang-Dar Juang; Kwan-Hwa Chi
Journal:  Radiat Oncol       Date:  2014-09-24       Impact factor: 3.481
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.